(Q21260332)

18 August 2022

27

Philip Asherson

Philip

Asherson

1 reference

18 August 2022

2

Susanne Bejerot

Susanne

Bejerot

1 reference

Josep Antoni Ramos-Quiroga

18 August 2022

23

object named as

Josep A Ramos-Quiroga

Josep A

Ramos-Quiroga

1 reference

18 August 2022

13

Chantal Henry

Chantal

Henry

1 reference

18 August 2022

Sandra J J Kooij

1

0 references

Andrew Blackwell

3

Andrew

Blackwell

1 reference

18 August 2022

Herve Caci

4

Herve

Caci

1 reference

18 August 2022

Miquel Casas-Brugué

5

Miquel

Casas-Brugué

1 reference

18 August 2022

Pieter J Carpentier

6

Pieter J

Carpentier

1 reference

18 August 2022

Dan Edvinsson

7

Dan

Edvinsson

1 reference

18 August 2022

John Fayyad

8

John

Fayyad

1 reference

18 August 2022

Karin Foeken

9

Karin

Foeken

1 reference

18 August 2022

Veronique Gaillac

11

Veronique

Gaillac

1 reference

18 August 2022

Ylva Ginsberg

12

Ylva

Ginsberg

1 reference

18 August 2022

Johanna Krause

14

Johanna

Krause

1 reference

18 August 2022

Michael B Lensing

15

Michael B

Lensing

1 reference

18 August 2022

Iris Manor

16

Iris

Manor

1 reference

18 August 2022

Helmut Niederhofer

17

Helmut

Niederhofer

1 reference

18 August 2022

Carlos Nunes-Filipe

18

Carlos

Nunes-Filipe

1 reference

18 August 2022

Martin D Ohlmeier

19

Martin D

Ohlmeier

1 reference

18 August 2022

Pierre Oswald

20

Pierre

Oswald

1 reference

18 August 2022

Stefano Pallanti

21

Stefano

Pallanti

1 reference

18 August 2022

Artemios Pehlivanidis

22

Artemios

Pehlivanidis

1 reference

18 August 2022

Maria Rastam

24

Maria

Rastam

1 reference

18 August 2022

Doris Ryffel-Rawak

25

Doris

Ryffel-Rawak

1 reference

18 August 2022

Steven Stes

26

Steven

Stes

1 reference

18 August 2022

Sandra JJ Kooij

Creative Commons Attribution 2.0 Generic

1

0 references

language of work or name

English

0 references

publication date

3 September 2010

2 references

13 March 2019

14 March 2019

2 references

13 March 2019

14 March 2019

10

0 references

issue

1

0 references

page(s)

67

0 references

copyright license

2 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

on focus list of Wikimedia project

14 March 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Evaluating dopamine reward pathway in ADHD: clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Deficits in attention, motor control, and perception: a brief review

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Attention-Deficit Hyperactivity Disorder in the context of a high intellectual quotient/giftedness

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Neurofeedback in adolescents and adults with attention deficit hyperactivity disorder

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

19 March 2017

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Efficacy of Neurofeedback Treatment in ADHD: The Effects on Inattention, Impulsivity and Hyperactivity: A Meta-Analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Clinical Correlates of ADHD in Females: Findings From a Large Group of Girls Ascertained From Pediatric and Psychiatric Referral Sources

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Anatomic magnetic resonance imaging studies of attention-deficit/hyperactivity disorder.

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Efficacy of meta-cognitive therapy for adult ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The age at onset of attention deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Practitioner review: Non-pharmacological treatments for ADHD: a lifespan approach

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Genome-wide association studies in ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Young adult gambling behaviors and their relationship with the persistence of ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Converging methods in studying attention-deficit/hyperactivity disorder: what can we learn from neuroimaging and genetics?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The use of psychotropic drugs in epilepsy: what every neurologist should know

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Lisdexamfetamine dimesylate for childhood ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Stimulant medication treatment of target behaviors in children with autism: a population-based study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

ADHD from a socio-economic perspective

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Functional magnetic resonance imaging evidence for abnormalities in response selection in attention deficit hyperactivity disorder: differences in activation associated with response inhibition but not habitual motor response

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Functional MRI in ADHD: a systematic literature review

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Impact of substance use disorder on ADHD and its treatment.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Environmental risk factors for attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Evaluating the evidence for and against the overdiagnosis of ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Drug and non-drug treatments of children with ADHD and tic disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Treatment strategies for co-occurring ADHD and substance use disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Cognitive remediation in ADHD: effects of periodic non-contingent alerts on sustained attention to response

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Cognitive-behavioral approaches to ADHD treatment in adulthood.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The worldwide prevalence of ADHD: is it an American condition?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Functional and psychosocial impairment in adults with undiagnosed ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The IMAGE project: methodological issues for the molecular genetic analysis of ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

A review of the use of modafinil for attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Adult ADHD and substance abuse: diagnostic and treatment issues

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Executive functioning in adult ADHD: a meta-analytic review

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Molecular genetics of attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Structural brain imaging of attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Psychosocial treatments for ADHD in teens and adults: a practice-friendly review

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Computerized training of working memory in children with ADHD--a randomized, controlled trial.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Non-stimulant medications in the treatment of ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Brain function and structure in adults with attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Genetics of adult attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Neuropsychological function in adults with attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Persistence of Attention-Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Attention deficit hyperactivity disorder (ADHD) and substance use disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Is clinic prevalence of ICD-10 hyperkinesis underestimated? Impact of increasing awareness by a questionnaire screen in an UK clinic

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Adults with ADHD. An overview

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The nature and heritability of attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Long-term prognosis in attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The stimulants revisited.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Antidepressants in the treatment of attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Hyperactivity and conduct problems as risk factors for adolescent development

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Hyperactive boys almost grown up. I. Psychiatric status

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Cerebral glucose metabolism in adults with hyperactivity of childhood onset

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Follow-ups of children with attention deficit hyperactivity disorder (ADHD). Review of literature

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Understanding comorbidity: a twin study of reading disability and attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Sex differences in ADHD: conference summary

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The relationship of attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: legal implications

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Research forum on psychological treatment of adults with ADHD.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Implications of early versus late onset of attention-deficit/hyperactivity disorder symptoms.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Psychopathology in adopted and nonadopted children: a clinical sample.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

ADHD, DAMP and other neurodevelopmental/psychiatric disorders in 6-year-old children: epidemiology and co-morbidity.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Age-dependent decline of attention deficit hyperactivity disorder

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Executive functioning in hyperactive children as young adults: attention, inhibition, response perseveration, and the impact of comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Adoptive and biological families of children and adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Marriages with children at medical risk: the transition to parenthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Genetic etiology of stability of attention problems in young adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

An international multicenter association study of the serotonin transporter gene in persistent ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: Issues of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Stopping and changing in adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

The pure electrophysiology of stopping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Brain dopamine transporter levels in treatment and drug naïve adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Preliminary evidence differentiating ADHD using brain SPECT imaging in older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Association between sleep problems and symptoms of attention-deficit/hyperactivity disorder in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

The psychosocial functioning of children and spouses of adults with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Gender differences in a sample of adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

How does being female assist help-seeking for mental health problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Attention deficit hyperactivity disorder in adults-early vs. late onset in a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Late-onset ADHD in adults: milder, but still dysfunctional.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Gender and comorbid psychopathology in adolescents with alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

DSM-IV combined type ADHD shows familial association with sibling trait scores: a sampling strategy for QTL linkage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Familial and genetic effects on motor coordination, laterality, and reading-related cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Antecedents of opioid dependence and personality disorder: attention-deficit/hyperactivity disorder and conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Psychiatric disorders and attempted suicide among adolescents with substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Electrophysiological correlates of response inhibition in children and adolescents with ADHD: influence of gender, age, and previous treatment history

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

ADHD in adults: a study of clinical characteristics, impairment and comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Abuse liability assessment of atomoxetine in a drug-abusing population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Emotional dysregulation in adult ADHD and response to atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Combination pharmacotherapy for adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Pharmacotherapy for adult ADHD.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Attention deficit hyperactivity disorder and substance use disorders

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

ADHD in adulthood--guidelines based on expert consensus with DGPPN support

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Physician Perceptions of the Use of Medications for Attention Deficit Hyperactivity Disorder

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Messy purse girls: adult females and ADHD.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

[Discussion of attention deficit-hyperactivity disorder (ADHD): facts, opinions and emotions].

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Adult psychiatric status of hyperactive boys grown up.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

[Mental disturbances in children and adolescents in Germany. Results of a representative study:age,gender and rater effects].

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Educational and occupational outcome of hyperactive boys grown up.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2942810

The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder

29 November 2018

1 reference

12 December 2020

Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials

1 reference

12 December 2020

The evaluation of attention deficit/hyperactivity disorder in family medicine residency programs

1 reference

12 December 2020

History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder

1 reference

12 December 2020

Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry

1 reference

12 December 2020

Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study

1 reference

12 December 2020

Childhood attention deficit/hyperactivity disorder in adults with anxiety disorders

1 reference

12 December 2020

Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes

1 reference

12 December 2020

Treatment of attention deficit and borderline personality disorders with psychostimulants: case report

1 reference

12 December 2020

Symptom profiles in children with ADHD: effects of comorbidity and gender

1 reference

12 December 2020

Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study

1 reference

12 December 2020

Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments

1 reference

12 December 2020

History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: A controlled study

1 reference

12 December 2020

Attention Deficit Hyperactivity Disorder

1 reference

12 December 2020

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

12 December 2020

Evaluation of Group Cognitive Behavioral Therapy for Adults With ADHD

1 reference

12 December 2020

Does the medicating ADHD increase or decrease the risk for later substance abuse?

1 reference

12 December 2020

Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study

1 reference

12 December 2020

Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community

1 reference

12 December 2020

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

1 reference

12 December 2020

Self-report of attention deficit and hyperactivity disorder in adolescents

1 reference

12 December 2020

High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study

1 reference

12 December 2020

Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms

1 reference

12 December 2020

Magnetic Resonance Imaging of Boys With Attention-Deficit/Hyperactivity Disorder and Their Unaffected Siblings

1 reference

12 December 2020

Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings

1 reference

12 December 2020

Striatal dysfunction in attention deficit and hyperkinetic disorder

1 reference

12 December 2020

Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults

1 reference

12 December 2020

Attention deficit hyperactivity disorder in childhood among adults with major depression

1 reference

12 December 2020

Attention deficit hyperactivity disorder, reading disability, and personality disorders in a prison population

1 reference

12 December 2020

Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections

1 reference

12 December 2020

Attention Deficit Hyperactivity Disorder (ADHD) in personality disordered offenders and the association with disruptive behavioural problems

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-67

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/1471-244X-10-67

1 reference

0 references

1 reference

1 reference

PubMed publication ID

20815868

1 reference